Life Insurance
Consensus Index

AI Consensus Fit Review

Mutual of Omaha Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders Fit Review

Mutual of Omaha is a good fit for a buyer who wants permanent indexed universal life coverage with a defined chronic-illness or long-term-care access feature, provided the applicant can meet rider underwriting.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Mutual of Omaha is a good fit for a buyer who wants permanent indexed universal life coverage with a defined chronic-illness or long-term-care access feature, provided the applicant can meet rider underwriting. Five of the seven platforms in this study named Mutual of Omaha during the ranking stage, with an average listed rank of 5.0 and a best rank of 1. The strongest reason to consider it is the pairing of Income Advantage IUL or Life Protection Advantage IUL with an optional Long-Term Care Rider and a built-in Chronic Illness Rider, backed by an A+ (Superior) AM Best rating. The main limitation is that no consumer-specific premium, rider charge, or complete state-specific contract was publicly verified, and the LTC Rider is reimbursement-based, separately underwritten, and unavailable in California.

Research Snapshot

FieldFinding
Platform mentions in ranking stage5 of 7 platforms (anthropic, deepseek, google, grok, perplexity)
Share of included platform responses71.4%
Average listed rank5.0
Best listed rank1 (grok)
Relevant product/model/planIncome Advantage IUL or Life Protection Advantage IUL issued by United of Omaha Life Insurance Company, with the optional Long-Term Care Rider; if LTC eligibility is not met, the policy may be issued with a Chronic Illness Rider (openai)
Overall use-case fitGood (six platforms rated good; google and grok rated strong)
Research date2026-09-20

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

  • Is Mutual of Omaha a good choice for Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders?
  • How often did AI platforms recommend Mutual of Omaha for IUL with chronic illness or long-term care riders?

Mutual of Omaha qualified because it offers a directly relevant product structure rather than a generic permanent policy. Five of the seven platforms named it during ranking discovery, and all seven platforms that produced a fit assessment rated it at least "good" for this use case (anthropic, deepseek, google, grok, kimi, openai, perplexity). The company's producer materials identify the optional Long-Term Care Rider as available on Income Advantage IUL and Life Protection Advantage IUL, both issued by United of Omaha life insurance Company [1].

The qualification rests on three supplied factors. First, product availability: multiple platforms independently located IUL products with a chronic-illness or LTC living-benefit feature [5]. Second, insurer strength: AM Best affirmed an A+ (Superior) Financial Strength Rating for Mutual of Omaha and subsidiaries including United of Omaha Life Insurance Company in 2026 [8]. Third, rider design: the LTC Rider uses defined ADL and cognitive triggers with a 90-calendar-day elimination period [1].

This is not a broad company review. Mutual of Omaha's ranking position here reflects only how platforms assessed it for Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders. Platform agreement does not prove product quality, and company-owned citations materially outnumber independent citations in the supplied evidence.

The Product, Model, Plan, or Service Most Relevant to Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders

Questions This Section Answers

  • Which Mutual of Omaha IUL product should a buyer choose if they need a long-term care rider versus a built-in chronic illness rider?
  • Does Mutual of Omaha's Income Advantage IUL or Life Protection Advantage IUL include a chronic illness rider at no additional cost?

The most relevant products are Income Advantage IUL and Life Protection Advantage IUL, both issued by United of Omaha Life Insurance Company, with the optional Long-Term Care Rider; if LTC eligibility is not met, the policy may be issued with a Chronic Illness Rider (openai). The two products differ in emphasis: Income Advantage IUL is described as emphasizing cash-value accumulation with transparent crediting, while Life Protection Advantage IUL emphasizes affordable death-benefit protection [12].

The rider architecture is the core of the fit. The Chronic Illness Rider is described in company materials as built into qualifying Income Advantage and Life Protection Advantage policies at no additional cost and without additional underwriting, available to all ages and risk classes [15]. The optional Long-Term Care Rider requires separate underwriting and carries a separate cost [18].

A material structural point: if the policy is issued with the Long-Term Care Rider, the Chronic Illness Rider is not included [20]. Platforms described the two riders as mutually exclusive at issue, so a buyer generally chooses one path rather than holding both.

Mutual of Omaha also offers Indexed Universal Life Express with Terminal, Chronic and Critical Illness Riders [21]. One platform flagged that availability of the Express combination with the LTC Rider was not verified in the reviewed public documents (openai). Buyers should treat the Express combination as a separate product question.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Mutual of Omaha's long-term care rider triggers and elimination period?
  • Is Mutual of Omaha's IUL long-term care rider reimbursement-based or indemnity-based?

Platforms agreed on several structural facts. The strongest agreement was on product availability: Income Advantage IUL and Life Protection Advantage IUL support a Long-Term Care Rider, and a Chronic Illness Rider is built into qualifying policies [23].

Platforms also agreed on benefit triggers. The LTC Rider generally requires the insured to be unable to perform two of six activities of daily living for 90 days or to require substantial supervision because of cognitive impairment [28]. The rider has a one-time 90-calendar-day elimination period [28].

Platforms agreed the LTC Rider is reimbursement-based rather than indemnity-based. Mutual of Omaha producer material explains that the rider reimburses covered expenses and requires qualifying expense documentation [33]. One platform described this as potentially less flexible than an indemnity rider but potentially avoiding certain practical limits of indemnity designs (openai).

Platforms agreed on acceleration mechanics. Producer materials state the rider can use a 1%, 2%, or 4% monthly acceleration percentage, with total benefits up to 100% of the initial specified death benefit, subject to stated dollar caps [28]. One platform reported maximum benefit limits of $2 million for the 1% and 2% options and $1.25 million for the 4% option [36].

Platforms agreed on financial strength. AM Best affirmed an A+ (Superior) Financial Strength Rating for Mutual of Omaha and subsidiaries including United of Omaha Life Insurance Company, with the affirmation reported in 2026 [38].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Is Mutual of Omaha's chronic illness rider indemnity or reimbursement, and why do sources disagree?
  • In which states is Mutual of Omaha's long-term care rider unavailable?

Platforms disagreed or were uncertain on several points, and buyers should treat these as open questions rather than settled facts.

Chronic illness rider payment method. One platform described the Chronic Illness Rider as indemnity-style, lump-sum, and unrestricted, requiring only proof that the insured is chronically ill [41]. Another platform described the LTC Rider as reimbursement-only with no lump sum [41]. A third platform noted benefit type was described variably across materials (grok). The supplied evidence does not resolve whether every chronic-illness benefit is paid without expense documentation.

Chronic illness fallback terms. One platform reported that if the applicant does not qualify for LTC Rider coverage, the policy will automatically be issued with the Chronic Illness Rider, but the exact chronic-illness benefit amount, triggers, and taxation were not located in reviewed public documents [43]. Another platform stated the Chronic Illness Rider is available to all ages and all risk classes [44]. These are consistent in direction but not fully reconciled.

State availability. Platforms agreed the LTC Rider is not available in California [45]. One platform stated Mutual of Omaha IUL products are not available in New York (anthropic). Another platform stated the chronic illness rider is available nationwide except that Indexed Universal Life is not available in New York (anthropic). The supplied evidence does not include a complete state-by-state availability list.

Product naming. One platform noted public materials vary on terminology and product naming across brochures, producer guides, and third-party summaries, so the exact rider package must be confirmed at quote time (perplexity). Another platform flagged that whether Income Advantage IUL or Life Protection Advantage IUL is currently available for new sales in 2026 is unclear from materials (kimi).

Index crediting terms. One platform reported Income Advantage IUL offers four crediting strategies on the S&P 500 and BofA U.S. Agility Index with participation rates of 100%, 140%, 60%, and 185%, and maximum illustrated rates of approximately 6.33% for the 100%/10% cap strategy and 5.72% for the BofA Agility uncapped strategy [49]. Another platform stated index crediting rates, caps, and participation rates were not found in available sources (kimi). This is a direct conflict in evidence coverage, not necessarily in product terms.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What long-term care settings does Mutual of Omaha's IUL LTC rider cover, and what monthly acceleration percentages are available?
  • Does Mutual of Omaha's IUL include a Guaranteed Refund Option, and what does it pay at year 15?

The LTC Rider covers several care settings. Producer materials describe reimbursement for services including nursing-home, assisted-living, home-health, and adult-day-care services [51]. The rider uses a 1%, 2%, or 4% monthly acceleration percentage, with total benefits up to 100% of the initial specified death benefit, subject to stated dollar caps [51].

Eligibility for the LTC Rider is narrow. Producer and brokerage materials state issue ages of 30 to 79 and generally require Table 4 or better with no flat extra ratings on the base policy [51]. Underwriting is separate from the base life policy, so an applicant may qualify for the IUL but be declined for the LTC Rider [57].

The Chronic Illness Rider is described as built in at no additional cost and without additional underwriting on qualifying policies [60]. One platform reported a flat $100 fee when the chronic illness benefit is used, plus an actuarial discount applied to the accelerated amount [62].

The Guaranteed Refund Option is a separate feature. One platform described it as a rider included at no additional cost on qualifying Income Advantage and Life Protection Advantage policies, providing seven 60-day windows with 50% of cumulative premiums at year 15 and up to 100% between years 20 and 25 [65]. The same platform reported eligibility restrictions: not available for substandard or tobacco cases under age 50, and on Life Protection Advantage not available over age 60 [67]. Another platform described the same rider with a cap at 80% of initial death benefit (anthropic).

IUL cash-value mechanics matter to this use case. One platform reported a 0% floor that ensures cash value will not decrease due to market declines [68]. The NAIC explains that indexed universal life combines fixed and variable features, and that universal life requires sufficient premium funding to keep coverage in force [69]. A floor does not eliminate policy-cost or lapse risk.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Mutual of Omaha's IUL with a long-term care rider cost per month, and is any premium publicly listed?
  • What fees apply when a Mutual of Omaha chronic illness or long-term care rider benefit is used?

No consumer-specific premium or rider-cost quote was publicly verified. Pricing confidence was rated low by four platforms (openai, anthropic, deepseek, perplexity) and moderate by two (grok, kimi). One platform rated pricing confidence high but still stated exact cost varies widely by age, gender, tobacco use, and underwriting risk class (google).

The clearest supplied pricing data point is a company comparison document showing a $7,210 annual premium for a male age 45, preferred non-tobacco, $1 million death benefit, Life Protection Advantage IUL with a 2% LTC or Chronic Illness rider, to age 90 guarantee, as of April 2025 [71]. This is a single illustration, not a rate schedule, and it predates the study date.

Industry benchmark figures are weaker evidence. One independent source suggested a healthy 45-year-old might pay $400 to $600 per month for a $500,000 policy with a chronic illness rider included, but that source was rated partial support and does not describe Mutual of Omaha's actual rates [72].

Known cost components include base IUL premiums and policy charges such as mortality, expense, and administrative charges, which are individualized and were not publicly quoted (openai). The LTC Rider has cost-of-insurance charges based on underwriting and selected benefit parameters [74]. One platform reported that once issued, LTC Rider cost-of-insurance charges are guaranteed not to increase over the life of the policy, which does not mean total policy costs or required premiums are fixed [75].

Fee events when benefits are used: one platform reported a flat $100 fee when the chronic illness or LTC benefit is used, plus an actuarial discount [76]. Another reported a $100 fee in Florida and $150 in some cases per claim (anthropic). One platform reported an actuarial discount and $100 fee on chronic illness acceleration (grok). These figures come from different platforms and were not reconciled.

Contract terms to verify include surrender charges, lapse provisions, and premium requirements. One platform reported surrender charges may last 10 to 15 years (deepseek), and another reported surrender charges in the first 14 years (grok). The NAIC buyer guidance states that universal life requires sufficient premium funding to keep coverage in force and that contracts may contain surrender and lapse consequences [77]. Using accelerated benefits reduces the remaining death benefit and may affect cash value and policy performance (openai).

Best Suited For

Questions This Section Answers

  • Who is Mutual of Omaha's IUL with a long-term care rider best suited for based on age and health class?
  • Is Mutual of Omaha a good fit for a buyer who wants permanent coverage plus a living-benefit rider in one policy?

Mutual of Omaha is best suited for buyers who want permanent life insurance, indexed interest-crediting potential, and an LTC reimbursement rider in one policy (openai). The strongest match is a buyer who can meet LTC Rider underwriting: issue ages 30 to 79, Table 4 or better, and no flat extra ratings on the base policy [78].

It also suits applicants who value a carrier with established financial-strength ratings and dedicated LTC experience [81]. Buyers who want a chronic-illness feature without additional underwriting may find the built-in Chronic Illness Rider relevant, since company materials describe it as included at no additional cost on qualifying policies [83].

Buyers who can accept that LTC benefits accelerate and reduce the death benefit rather than provide a separate unlimited LTC pool are a better match than buyers seeking standalone LTC coverage (openai). Buyers choosing between the two IUL products should note that Income Advantage IUL emphasizes cash-value accumulation while Life Protection Advantage IUL emphasizes affordable death-benefit protection [85].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Mutual of Omaha for Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders?
  • Is Mutual of Omaha's IUL a poor fit for a buyer who wants indemnity-style long-term care payments?

Mutual of Omaha is probably not best suited for buyers who want a standalone LTC policy with benefits designed primarily for care expenses (openai). It is also a poor fit for buyers who need indemnity payments without submitting qualifying expense documentation, because the LTC Rider uses a reimbursement model [87].

Applicants outside the LTC Rider eligibility window are poorly served. The rider is limited to issue ages 30 to 79 and generally requires Table 4 or better with no flat extras [88]. One platform stated applicants over age 79 or with health ratings worse than Table 4 or flat extra charges cannot add the LTC rider (anthropic). California residents cannot access the LTC Rider at all [90].

Buyers seeking transparent online pricing or a guaranteed investment return are also a weak match, since no consumer-specific premium was publicly verified and IUL cash value depends on credited interest, charges, and policy design (openai). Buyers who want both the chronic illness and LTC riders on the same policy face a structural limit, because the two are mutually exclusive at issue [93].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Mutual of Omaha for a buyer who needs cash indemnity long-term care benefits?
  • When is a standalone long-term care policy better than Mutual of Omaha's IUL with an LTC rider?

A standalone LTC policy may be better when the primary objective is maximizing dedicated LTC benefits rather than combining care funding with life insurance (openai). One platform specifically noted that a dedicated long-term care insurance policy may be better if the buyer wants more direct LTC coverage and is not primarily seeking life insurance cash value (perplexity).

Another carrier may be better when the buyer prioritizes indemnity-style rider payments, broader chronic-illness triggers, lower rider costs, stronger guaranteed values, or more transparent illustrations (openai). One platform named John Hancock LifeCare as an alternative for buyers who want cash indemnity LTC benefits up to IRS per diem limits rather than reimbursement-only benefits, and for buyers who want 7702B-qualified coverage with a compound inflation option [94]. That comparison comes from a single platform and should be independently verified.

A simpler guaranteed universal-life or whole-life policy may be better when permanent death-benefit guarantees matter more than indexed cash-value potential (openai). One platform suggested guaranteed universal life for buyers who need a no-lapse guarantee without cash value volatility (deepseek). Buyers who need critical illness acceleration rather than chronic or LTC triggers may need a different product or carrier (kimi).

Geographic and health constraints also push buyers elsewhere. Buyers over age 79, in California, or with health ratings worse than Table 4 may need carriers with higher age limits, state-compliant riders, or more inclusive underwriting (anthropic). Buyers in New York may need alternative carriers licensed in that state (anthropic).

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Mutual of Omaha about rider forms and state availability before signing?
  • What illustration scenarios should a buyer request from Mutual of Omaha before buying an IUL with an LTC rider?

The supplied platform responses converge on a verification list. Buyers should confirm which legal insurer issues the policy in their state and the exact policy and rider form numbers (openai). They should confirm whether Income Advantage IUL or Life Protection Advantage IUL is available with the LTC Rider for their age, health class, state, and desired face amount [96].

If the LTC Rider is declined, buyers should ask what exact Chronic Illness Rider is issued, including triggers, benefit limits, waiting period, payment method, and cost (openai). They should confirm whether LTC benefits are reimbursement-based for every selected benefit and what documentation and covered-service rules apply [98].

Benefit parameters to confirm include the selected 1%, 2%, or 4% monthly benefit, total rider limit, dollar cap, and 90-day elimination-period mechanics [99]. Buyers should request guaranteed versus non-guaranteed premium, cash-value, death-benefit, and lapse outcomes under conservative, current, and adverse illustrations (openai).

Cost and contract items to confirm include all base-policy and rider charges, surrender charges, loan provisions, index-crediting caps or participation rates, and premium requirements (openai, deepseek). Buyers should ask how accelerating benefits affects the death benefit, cash value, policy loans, premiums, and beneficiaries (openai). They should also confirm whether the state-specific rider qualifies for intended federal and state tax treatment, and whether a standalone LTC policy would provide more useful benefits for their expected care setting and budget [101].

Final AI Consensus Verdict

Mutual of Omaha is a good fit for indexed universal life insurance with chronic illness or long-term care riders, with meaningful caveats. Five of seven platforms named it in ranking discovery, and all seven fit assessments rated it good or strong. The strongest case rests on Income Advantage IUL or Life Protection Advantage IUL paired with an optional LTC Rider and a built-in Chronic Illness Rider, plus an A+ (Superior) AM Best rating [102].

The limitations are material and should shape the decision. The LTC Rider is reimbursement-based, separately underwritten, limited to issue ages 30 to 79 with Table 4 or better, and unavailable in California [104]. The chronic illness and LTC riders are mutually exclusive at issue [108]. No consumer-specific premium, rider charge, surrender schedule, or complete state-specific contract was publicly verified, and pricing confidence was low across most platforms.

Platform agreement here reflects how AI systems assessed fit from available sources; it does not prove product quality or competitive pricing. Buyers should treat this as a starting point for a state-specific illustration and a comparison against standalone LTC coverage and competing IUL designs. The broader Indexed Universal Life Insurance With Chronic Illness or Long-Term Care Riders consensus index shows how Mutual of Omaha ranks against other carriers for this use case.

How This Review Was Produced

This review synthesizes seven platform responses collected for a single buyer prompt about indexed universal life insurance with chronic illness or long-term care riders. The study date is 2026-09-20. Five of the seven platforms named Mutual of Omaha during ranking discovery: anthropic, deepseek, google, grok, and perplexity. All seven platforms produced a fit assessment, with ratings of good (anthropic, deepseek, kimi, openai, perplexity) and strong (google, grok).

Each platform supplied its own citations, product naming, pricing notes, and verification questions. This review preserves those inputs, including conflicts, rather than resolving them. Company-owned citations materially outnumber independent citations in the supplied evidence, so company claims are described as company-reported rather than independently verified. No personal testing, customer experience, or independent verification was performed.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date: deepseek reported 2026-01-15, while the other six platforms reported 2026-09-21. Platform-reported dates are provenance metadata and do not independently prove freshness.

The supplied URLs were collected from platform responses and were not independently validated. Citations are platform-reported evidence, not independently verified facts. One platform (deepseek) reported search disabled, so its claims require explicit verification before being described as current facts.

Company-owned sources dominate the evidence base, which limits independent corroboration of rider terms, pricing, and availability. No consumer-specific premium, rider charge, surrender schedule, or complete state-specific rider contract was located in the reviewed public materials. Product naming varies across brochures, producer guides, and third-party summaries, and the exact rider package must be confirmed at quote time. Platform agreement on fit does not establish product quality, competitive pricing, or suitability for any individual buyer.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence108 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c2
    3. AI research evidence record anthropic:1-2
    4. AI research evidence record perplexity:c3
    5. AI research evidence record deepseek:c1
    6. AI research evidence record deepseek:c2
    7. AI research evidence record perplexity:c1
    8. AI research evidence record openai:c6
    9. AI research evidence record anthropic:28-1
    10. AI research evidence record anthropic:10-8
    11. AI research evidence record anthropic:10-9
    12. AI research evidence record anthropic:12-6
    13. AI research evidence record anthropic:24-18
    14. AI research evidence record anthropic:24-20
    15. AI research evidence record anthropic:5-4
    16. AI research evidence record anthropic:40-2
    17. AI research evidence record anthropic:40-8
    18. AI research evidence record anthropic:10-19
    19. AI research evidence record perplexity:c9
    20. AI research evidence record anthropic:8-2
    21. AI research evidence record anthropic:4-1
    22. AI research evidence record perplexity:c12
    23. AI research evidence record anthropic:1-2
    24. AI research evidence record anthropic:5-3
    25. AI research evidence record deepseek:c1
    26. AI research evidence record perplexity:c1
    27. AI research evidence record kimi:omaha_rider_comparison
    28. AI research evidence record openai:c1
    29. AI research evidence record anthropic:10-8
    30. AI research evidence record perplexity:c10
    31. AI research evidence record anthropic:10-9
    32. AI research evidence record perplexity:c8
    33. AI research evidence record openai:c5
    34. AI research evidence record anthropic:13-5
    35. AI research evidence record perplexity:c5
    36. AI research evidence record grok:0
    37. AI research evidence record google:1.1.7
    38. AI research evidence record openai:c6
    39. AI research evidence record anthropic:28-1
    40. AI research evidence record anthropic:28-5
    41. AI research evidence record kimi:omaha_rider_comparison
    42. AI research evidence record kimi:omaha_gbs_comparison
    43. AI research evidence record openai:c1
    44. AI research evidence record anthropic:40-2
    45. AI research evidence record anthropic:1-11
    46. AI research evidence record anthropic:18-1
    47. AI research evidence record grok:0
    48. AI research evidence record anthropic:15-1
    49. AI research evidence record anthropic:12-12
    50. AI research evidence record anthropic:12-13
    51. AI research evidence record openai:c1
    52. AI research evidence record perplexity:c1
    53. AI research evidence record anthropic:13-5
    54. AI research evidence record perplexity:c5
    55. AI research evidence record anthropic:13-7
    56. AI research evidence record anthropic:13-8
    57. AI research evidence record anthropic:10-19
    58. AI research evidence record anthropic:10-20
    59. AI research evidence record perplexity:c9
    60. AI research evidence record anthropic:5-4
    61. AI research evidence record anthropic:40-8
    62. AI research evidence record perplexity:c4
    63. AI research evidence record google:1.1.2
    64. AI research evidence record kimi:omaha_rider_comparison
    65. AI research evidence record anthropic:12-8
    66. AI research evidence record anthropic:12-9
    67. AI research evidence record anthropic:12-11
    68. AI research evidence record anthropic:3-5
    69. AI research evidence record openai:c4
    70. AI research evidence record openai:c7
    71. AI research evidence record anthropic:1-5
    72. AI research evidence record anthropic:43-1
    73. AI research evidence record anthropic:43-13
    74. AI research evidence record openai:c1
    75. AI research evidence record openai:c2
    76. AI research evidence record perplexity:c4
    77. AI research evidence record openai:c7
    78. AI research evidence record openai:c1
    79. AI research evidence record anthropic:13-7
    80. AI research evidence record anthropic:13-8
    81. AI research evidence record openai:c6
    82. AI research evidence record anthropic:28-1
    83. AI research evidence record anthropic:5-4
    84. AI research evidence record anthropic:40-8
    85. AI research evidence record anthropic:24-18
    86. AI research evidence record anthropic:24-20
    87. AI research evidence record openai:c5
    88. AI research evidence record anthropic:13-7
    89. AI research evidence record anthropic:13-8
    90. AI research evidence record anthropic:1-11
    91. AI research evidence record anthropic:18-1
    92. AI research evidence record grok:0
    93. AI research evidence record anthropic:8-2
    94. AI research evidence record kimi:johnhancock_lifecare
    95. AI research evidence record kimi:johnhancock_lifecare_guide
    96. AI research evidence record anthropic:13-7
    97. AI research evidence record anthropic:13-8
    98. AI research evidence record openai:c5
    99. AI research evidence record openai:c1
    100. AI research evidence record anthropic:13-5
    101. AI research evidence record anthropic:41-3
    102. AI research evidence record openai:c6
    103. AI research evidence record anthropic:28-1
    104. AI research evidence record openai:c5
    105. AI research evidence record anthropic:13-7
    106. AI research evidence record anthropic:13-8
    107. AI research evidence record anthropic:1-11
    108. AI research evidence record anthropic:8-2

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
53
Ranking mentions
5 of 7
Platform share
71%
Final consensus rank
#3

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

17 independent · 33 company-owned · 3 unclear

Evidence support

44 direct · 8 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

a7fa5e882c241edcb55b6f0cab37841ee26f3bd4c08897938cca374d7fb39ced